Management of Adult Patients with Acute Respiratory Distress Syndrome
Publication Date: November 29, 2023
Key Points
Key Points
- The acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure characterized by acute hypoxemia and bilateral radiographic infiltrates.
- ARDS management remains largely supportive, high mortality rates persist, with those who survive often facing long-term impairments.
- Since 2017, new data have emerged addressing multiple ARDS therapies and supportive care interventions that include corticosteroids, venovenous extracorporeal membrane oxygenation (VV-ECMO) neuromuscular blocking agents (NMBAs), and positive end expiratory pressure (PEEP), prompting an update to the guidelines.
- This guideline updates and adds to recommendations for the management of patients with ARDS (Figure 1).
Treatment
...eatment...
...Recommendations in This Guideline
...est using corticosteroids for patients with ARDS....
We suggest using venovenous extracorpo...
We suggest using neuromuscular blockers i...
...uggest using higher PEEP without lung...
...commend against using prolonged lung...
...mendations From the 2017 Guideline That Rem...
...ing mechanical ventilation strategies th...
...ommend prone positioning for >12 hours per day...
...mend against the routine use of high-f...
...t ATS Guidelines for the Management of AR...
...2: Precautions and Practical Considerati...